Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Skaug

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Rheumatology|October 10, 2018
Antinuclear antibodies in the general population: positive association with inflammatory and vascular biomarkers but not traditional cardiovascular risk factorsElizabeth Blair Solow, Wanpen Vongpatanasin, Brian Skaug, et al.
Journal of the American College of Cardiology|June 20, 2015
Antinuclear Antibodies Are Associated With All-Cause Mortality and Cardiovascular Outcomes in the General PopulationElizabeth Blair Solow, Wanpen Vongpatanasin, Brian Skaug, et al.
Developmental Cell|March 15, 2011
Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signalingKe Xu, Anastasia Sacharidou, Stephen Fu, et al.
Seminars in Arthritis and Rheumatism|June 26, 2022
False positive anti-Topoisomerase I (Scl-70) antibody results in clinical practice: A case series from a scleroderma referral centerBrian H Lam, Shervin Assassi, Julio Charles, et al.
Arthritis Care & Research|June 22, 2026
Determinants of body mass index in early systemic sclerosis: implications for nutritional risk stratificationAli Y Ayla, Meng Zhang, Bingrui Chen, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Extensive and Persistent Extravascular Dermal Fibrin Deposition Characterizes Systemic SclerosisJeffrey L Browning, Jag Bhawan, Anna Tseng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2018
Foxo3 Promotes Apoptosis of B Cell Receptor-Stimulated Immature B Cells, Thus Limiting the Window for Receptor EditingKristina Ottens, Rochelle M Hinman, Evan Barrios, et al.
Annals of the Rheumatic Diseases|August 24, 2019
Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosisMinghua Wu, Brian Skaug, Xiongjie Bi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2015
Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody LevelsJessica Mayeux, Brian Skaug, Wei Luo, et al.
Annals of the Rheumatic Diseases|December 23, 2021
Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over timeBrian Skaug, Marka A Lyons, William R Swindell, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Rheumatology|October 10, 2018
Antinuclear antibodies in the general population: positive association with inflammatory and vascular biomarkers but not traditional cardiovascular risk factorsElizabeth Blair Solow, Wanpen Vongpatanasin, Brian Skaug, et al.
Journal of the American College of Cardiology|June 20, 2015
Antinuclear Antibodies Are Associated With All-Cause Mortality and Cardiovascular Outcomes in the General PopulationElizabeth Blair Solow, Wanpen Vongpatanasin, Brian Skaug, et al.
Developmental Cell|March 15, 2011
Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signalingKe Xu, Anastasia Sacharidou, Stephen Fu, et al.
Seminars in Arthritis and Rheumatism|June 26, 2022
False positive anti-Topoisomerase I (Scl-70) antibody results in clinical practice: A case series from a scleroderma referral centerBrian H Lam, Shervin Assassi, Julio Charles, et al.
Arthritis Care & Research|June 22, 2026
Determinants of body mass index in early systemic sclerosis: implications for nutritional risk stratificationAli Y Ayla, Meng Zhang, Bingrui Chen, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Extensive and Persistent Extravascular Dermal Fibrin Deposition Characterizes Systemic SclerosisJeffrey L Browning, Jag Bhawan, Anna Tseng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2018
Foxo3 Promotes Apoptosis of B Cell Receptor-Stimulated Immature B Cells, Thus Limiting the Window for Receptor EditingKristina Ottens, Rochelle M Hinman, Evan Barrios, et al.
Annals of the Rheumatic Diseases|August 24, 2019
Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosisMinghua Wu, Brian Skaug, Xiongjie Bi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2015
Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody LevelsJessica Mayeux, Brian Skaug, Wei Luo, et al.
Annals of the Rheumatic Diseases|December 23, 2021
Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over timeBrian Skaug, Marka A Lyons, William R Swindell, et al.
Pageof 4